COPD Management and Pulmonary Disease

Selected news for the healthcare topic - COPD Management, and the healthcare topic - Pulmonary Disease We have 19 shared news items for this connection to-date.

Please provide a valid email address.
COPD Management Shares Healthcare News With (link):
Other Healthcare Entities

Selected Headlines

Date Headline (link) Source Relevant Snippet
11/30/2020 Factors Affecting Community Pharmacist's Knowledge About Chronic Obstructive Pulmonary Disease (COPD) Management in China: A Cross-Sectional Survey Study ... pulmonary disease (COPD) has become a significant risk factor that threatens public health. Many studies have confirmed that the professional services for COPD patients by community pharmacists can improve comprehensive benefits. However, there‚Aos less research investigating the factors affecting community pharmacists‚Ao knowledge about COPD management. Therefore, this study aimed to investigate the knowledge of COPD among community pharmacists in China and analyze the factors affecting community pharmacist‚Aos ...
11/20/2020 National health groups offer support for COPD patients and caregivers amid pandemic An estimated 16.4 million Americans are living with chronic obstructive pulmonary disease (COPD) ‚Ai a chronic lung disease that makes it difficult to breathe ‚Ai which places them at an increased risk for more severe ... Byron Thomashow, M.D, Chief Medical Officer, COPD Foundation Questions about COPD management in the COVID era?The Centers for Disease Control and Prevention (CDC) has identified those living with COPD among those at greater risk ...
11/19/2020 The caregiver difference: One man’s journey caring for his father’s COPD | Ask.com - What's Your Question? 2020-11-18T11:01:01 (BPT) - When Justin found out his dad had been diagnosed with chronic obstructive pulmonary disease (COPD), he wasn't sure what to expect. Without knowing anything about the condition, he didn't realize that becoming a ... between patients and their doctors, which create barriers to optimal COPD management. The survey, which was fielded to 351 people with COPD, 151 caregivers, 249 primary care physicians and 252 pulmonologists, found that caregivers play ...
9/17/2020 Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical Touchpoints and Support for COVID-19 and COPD Management PR Newswire ... addition of new connected health devices to ensure timely clinical touchpoints for Coronavirus Disease 2019 (COVID-19) and Chronic Obstructive Pulmonary Disease (COPD) management. The new peripherals, which include a thermometer, peak flow meter, spirometer ... devices to ensure timely clinical touchpoints for COVID-19 and COPD management. The new peripherals complement the company’s already rich ecosystem of connected health devices and will provide clinical teams access to patient generated health ...
9/17/2020 Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical Touchpoints and Support for COVID-19 and COPD Management ... eNEWSLETTERS TMCnet News Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical Touchpoints and Support for COVID-19 and COPD Management [September 17, 2020] Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical ... touchpoints for Coronavirus Disease 2019 (COVID-19) and Chronic Obstructive Pulmonary Disease (COPD) management. The new peripherals, which include a thermometer, peak flow meter, spirometer, and pulse oximeter, complement the company's already rich ecosystem of ...
8/11/2020 Zhongchao Inc. Develops Live Interactive Courses Promoting the Global Initiative for Chronic Obstructive Lung Disease PR Newswire ... pulmonary disease ("COPD") and to improve prevention and treatment of this lung disease for patients around the world. GOLD's primary objectives include: i) Recommend effective COPD management and prevention strategies for use in all countries; ii) Increase awareness of the medical community, public health officials and the general public that COPD is a public health problem; iii) Decrease morbidity and mortality from COPD through implementation and evaluation of effective programs ...
8/11/2020 Zhongchao Inc. Develops Live Interactive Courses Promoting the Global Initiative for Chronic Obstructive Lung Disease | BioSpace BioSpace ... pulmonary disease ("COPD") and to improve prevention and treatment of this lung disease for patients around the world. GOLD's primary objectives include: i) Recommend effective COPD management and prevention strategies for use in all countries; ii) Increase awareness of the medical community, public health officials and the general public that COPD is a public health problem; iii) Decrease morbidity and mortality from COPD through implementation and evaluation of effective programs ...
6/25/2020 Breztri Aerosphere Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial ... of moderate or severe exacerbations compared with two dual-combination therapies in patients with moderate to very severe chronic obstructive pulmonary disease (COPD). 1 Compared with Bevespi Aerosphere (glycopyrronium/formoterol fumarate), Breztri Aerosphere achieved a ... on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of Breztri Aerosphere were consistent with the known profiles of the dual comparators. In the trial, the most frequently ...
6/25/2020 PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial | Financial Buzz ... of moderate or severe exacerbations compared with two dual-combination therapies in patients with moderate to very severe chronic obstructive pulmonary disease (COPD). Compared with glycopyrronium/formoterol fumarate, PT010 achieved a 24% reduction (p 0.001 ... on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported ...
6/24/2020 PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial | BioSpace BioSpace ... findings also show that reducing risk of all-cause mortality is achievable and could transform treatment goals in chronic obstructive pulmonary disease.” Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, said: “Chronic obstructive pulmonary disease ... on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported ...
6/24/2020 PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial - GuruFocus.com ... of moderate or severe exacerbations compared with two dual-combination therapies in patients with moderate to very severe chronic obstructive pulmonary disease (COPD). Compared with glycopyrronium/formoterol fumarate, PT010 achieved a 24% reduction (p 0.001 ... on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported ...
6/24/2020 PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial Business Wire ... of moderate or severe exacerbations compared with two dual-combination therapies in patients with moderate to very severe chronic obstructive pulmonary disease (COPD). Compared with glycopyrronium/formoterol fumarate, PT010 achieved a 24% reduction (p 0.001 ... on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported ...
6/2/2020 Measuring disease activity in COPD: is clinically important deterioration the answer? Given the heterogeneity of chronic obstructive pulmonary disease (COPD), personalized clinical management is key to optimizing patient outcomes. Important treatment goals include minimizing disease activity and preventing disease progression; however, quantification of these components remains ... the widely acknowledged need for an individualized holistic approach to COPD management, monitoring short-term CID has the potential to facilitate early identification of suboptimal treatment responses and patients at risk of increased disease progression ...
11/26/2019 COPD Awareness Month – Take Control of Your Respiratory Heath ... designed as a way for individuals to learn more about this disease while providing increased support for those currently seeking COPD management. With over 15.3 million Americans currently diagnosed with COPD, most people know someone ... COPD? COPD is a commonly used acronym for chronic obstructive pulmonary disease, a term that refers to both chronic bronchitis along with emphysema. With either manifestation of COPD, individuals find it difficult to breathe. One ...
11/26/2019 Diagnosed with COPD? you Can take charge Of Your Health! ... He earned his B.A. in psychology from UC Irvine and his PharmD from Touro College. Getting diagnosed with Chronic Obstructive Pulmonary Disease (COPD) can be scary and overwhelming. Have you been told that you have ... my patients with the knowledge and tools they need for COPD management and to overcome the fear and anxiety of being labeled with a Chronic Respiratory condition. Moment of Truth You just found out why ...
11/20/2019 World COPD Day: Pulmonologist Tells Everything You Ever Wanted To Know About COPD Drink plenty of fluids for COPD management Maintaining a healthy weight is also important Be on point with your medicines to control COPD World COPD Day: November 20 is observed as World Chronic Obstructive Pulmonary Disease (COPD) Day. This day is meant to raise awareness about COPD which is referred to a group of slowly progressing lung diseases. Emphysema and chronic bronchitis are common lung diseases. Emphysema slowly destroys air ...
5/28/2019 Assessing spirituality: is there a beneficial role in the management of COPD? Nature ... the confidence to raise it with patients and how to integrate spiritual approaches into holistic COPD care. Introduction Chronic obstructive pulmonary disease (COPD) is a complex, heterogeneous disease characterized by persistent airflow limitation and repeated ... life status and being mindful. 31 This has advantages in COPD management, with promising results from mindfulness-based interventions added in pulmonary rehabilitation (PR). 32 Importantly, literature reveals the desire of patients for their religion ...
4/11/2019 Chronic Obstructive Pulmonary Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 -2026 | Markets Insider Business Insider NEW YORK , April 11, 2019 /PRNewswire/ -- Global Chronic Obstructive Pulmonary Disease Treatment Market: Overview This report analyzes the current and future scenario of the global chronic obstructive pulmonary disease (COPD) treatment market.Rise in prevalence of ... Additionally, increase in the geriatric population, rise in importance of COPD management, and surge in the number of respiratory care centers contribute to the growth of the global market. According to the Global Initiative for ...
11/16/2017 Trelegy Ellipta Once-Daily Single Inhaler Triple Therapy Gains Marketing Authorisation in Europe for the Treatment of COPD | Business Wire Business Wire ... fluticasone furoate/umeclidinium/vilanterol, ‘FF/UMEC/VI’) as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid ... single inhalation. We believe this is an important innovation in COPD management and look forward to making it available for appropriate patients with COPD.” Mike Aguiar, CEO of Innoviva, Inc., said, “Knowing that appropriate COPD ...